Fra(10)(q25): the BrdU effect is substitution-dependent

Area of Science:

• Genetics
• Molecular Biology
• Cell Biology

Background:

• Fragile sites, such as fra(10)(q25), are specific points on chromosomes prone to breakage.
• Bromodeoxyuridine (BrdU) is a thymidine analog incorporated into DNA during replication.
• BrdU's effects on cells can be mediated by DNA substitution or concentration.

Purpose of the Study:

• To investigate the mechanism by which bromodeoxyuridine (BrdU) induces or enhances fra(10)(q25) expression.
• To determine whether BrdU's effect is dependent on its concentration or its incorporation level into DNA.
• To identify the critical timing of BrdU incorporation for its effect on fra(10)(q25).

Main Methods:

• Culturing cells in the presence of varying concentrations and substitution levels of BrdU.
• Analyzing fra(10)(q25) expression levels under different BrdU conditions.
• Assessing the reversibility of BrdU's effect by removing it and adding deoxythymidine at different time points before mitosis.

Main Results:

• BrdU induction/enhancement of fra(10)(q25) expression is primarily substitution-dependent, with little effect from concentration variations.
• fra(10)(q25) expression increases with higher BrdU substitution levels, reaching near 100% at 100% substitution.
• The critical period for BrdU incorporation is 8-9 hours before mitosis, and the effect becomes irreversible after this window.

Conclusions:

• BrdU's influence on fra(10)(q25) expression is directly linked to its incorporation into DNA, not its concentration in the medium.
• The timing of BrdU incorporation relative to mitosis is crucial for its observed effects on fra(10)(q25).
• Similar effects were observed with Iododeoxyuridine, suggesting a class effect for halogenated pyrimidines.